https://www.selleckchem.com/pr....oducts/Staurosporine
Finally, we demonstrated that ensartinib had no significant effect on the mRNA-level expression of examined transporters and enzymes in physiological and lung tumor cellular models. In conclusion, ensartinib may perpetrate clinically relevant pharmacokinetic DDIs and modulate ABCB1-, ABCG2-, and CYP3A4-mediated MDR. The in vitro findings presented here will provide a valuable foundation for future in vivo investigations.Long non-coding RNAs (lncRNAs) play important roles in the regulation of complex cellular processes, including t
Like
Comment
Share
